KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Capital Expenditures: 2010-2024

Historic Capital Expenditures for Supernus Pharmaceuticals (SUPN) over the last 14 years, with Dec 2024 value amounting to $725,000.

  • Supernus Pharmaceuticals' Capital Expenditures fell 35.50% to $129,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year increase of 136.13%. This contributed to the annual value of $725,000 for FY2024, which is 31.58% up from last year.
  • Latest data reveals that Supernus Pharmaceuticals reported Capital Expenditures of $725,000 as of FY2024, which was up 31.58% from $551,000 recorded in FY2023.
  • Over the past 5 years, Supernus Pharmaceuticals' Capital Expenditures peaked at $3.4 million during FY2020, and registered a low of $412,000 during FY2022.
  • Over the past 3 years, Supernus Pharmaceuticals' median Capital Expenditures value was $551,000 (recorded in 2023), while the average stood at $562,667.
  • In the last 5 years, Supernus Pharmaceuticals' Capital Expenditures dropped by 26.06% in 2020 and then surged by 33.74% in 2023.
  • MRY analysis of 4 years shows Supernus Pharmaceuticals' Capital Expenditures stood at $3.4 million in 2020, then plummeted by 88.05% to $412,000 in 2022, then skyrocketed by 33.74% to $551,000 in 2023, then surged by 31.58% to $725,000 in 2024.
  • Its Capital Expenditures stands at $725,000 for FY2024, versus $551,000 for FY2023 and $412,000 for FY2022.